Trial · NCT07852910
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 30 of 30
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Impulse control (cognitive function) | At the start (hour 0) and end of exposure (hour 8) | Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device. |
| Secondary | Reaction time (cognitive function) | At the start (hour 0) and end of exposure (hour 8) | Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of reaction time. Participants will be asked to initiate a movement of the device in response to a visual cue. |
| Secondary | Cardiac response to standing from supine (30:15 Ratio) | At the start (hour 0) and end of exposure (hour 8) | Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest). Assessment is performed in the morning prior to and following daytime exposure. |
| Secondary | Heart rate (AUC) | End of 8-hour exposure | Area under the curve of heart rate (in bpm-hours) |
| Secondary | Heart rate (Peak) | End of 8-hour exposure | Peak Heart rate (15-min average) during the 8-hour exposure |
| Secondary | Core temperature (AUC) | End of 8-hour exposure | Area under the curve of rectal temperature (in degree-hours) |
| Secondary | Core temperature (hourly) | Hourly during the 8-hour exposure | Rectal temperature measured at each hour of exposure (15-min average) |
| Secondary | Mean skin temperature (Peak) | End of 8-hour exposure | Peak mean skin temperature (15-min average) during the 8-hour exposure |
| Secondary | Mean skin temperature (AUC) | End of 8-hour exposure | Area under the curve of mean skin temperature (in degree-hours) |
| Secondary | Urine specific gravity | At the start (hour 0) and end of exposure (hour 8) | Urine specific gravity measured by handheld refractometer |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07852910/registered?page=2